HomeRAD • ASX
Radiopharm Theranostics Ltd
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.22M | -40.04% |
Operating expense | 3.52M | -12.41% |
Net income | -9.36M | 20.90% |
Net profit margin | -768.27 | -31.94% |
Earnings per share | -0.01 | — |
EBITDA | -9.14M | -4.52% |
Effective tax rate | -0.52% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 36.44M | 1,823.88% |
Total assets | 92.45M | 46.07% |
Total liabilities | 40.45M | 3.85% |
Total equity | 52.00M | — |
Shares outstanding | 2.20B | — |
Price to book | 1.20 | — |
Return on assets | -26.78% | — |
Return on capital | -47.61% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -9.36M | 20.90% |
Cash from operations | -11.11M | -88.71% |
Cash from investing | 1.50M | — |
Cash from financing | 18.30M | 1,749.57% |
Net change in cash | 8.93M | 282.17% |
Free cash flow | -3.59M | 31.39% |
Previous close
$0.024
Day range
$0.023 - $0.024
Year range
$0.021 - $0.057
Market cap
44.73M AUD
Avg Volume
7.86M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
About
Founded
2021
Website
